Open Access
Subscription Access
Open Access
Subscription Access
Evaluation of Dermatological Adverse Drug Reactions in a Tertiary Care Hospital of Northern India
Subscribe/Renew Journal
In clinical practice dermatological reactions are common but comprehensive information regarding their incidence, severity is often not available as many cases go unreported. The objective of this study was to evaluate the types of dermatological adverse drug reactions (ADRs) in a tertiary care hospital and determine their causal relationship with the offending drug. This prospective, observational study was conducted at GSVM medical college Kanpur, Northern India for one year. Patients of all age and either sex were included. Dermatological adverse drug reactions were reported by the physicians of various department of the hospital and their causality assessments were performed as per World health organization (WHO) Uppsala monitoring centre (UMC), Expanded Rawlins and Thompson’s classification was used for determining type of ADRs, outcome and seriousness of ADR were assessed as per WHO. Descriptive statistics were used for data analysis. A total of 105 dermatological adverse drug reactions were reported from various departments of this tertiary care hospital. Most of the adverse drug reactions were observed in the age group of 0–20 year. Rash (35 ADRs) was commonly reported reaction. Anticancer drugs lead to 48 ADRs (mainly with Paclitaxel+Carboplatin-11, Adriamycin+Cyclophosphamide-7), followed by Antibacterial with 28 ADRs (mainly with Vancomycin-6, Cefixime-4 and Amoxicillin-4). A total of 8 ADRs were of serious type mainly with Vancomycin-Red man syndrome-6, Carbamazepine-toxic epidermal necrolysis-1 and Nimesulide-Steven Johnson Syndrome-1. Most of the adverse drug reactions on causality assessment were possible (77, 73.33%) and Probable (28, 26.67%) in nature. Type -B ADRs account for 2/3rd of the total dermatological ADRs. It’s highly emphasized for careful monitoring for ADRs associated with high risk drugs and more awareness should be created.
Keywords
Adverse Drug Reaction, Causality, Dermatological, Rash.
Subscription
Login to verify subscription
User
Font Size
Information
- Parthasarathi, G., Karin, N., Milap, C.N., A Textbook of Clinical Pharmacy Practice, Essential Concepts and skills, 2nd edition, India; Universities Press Private Limited 2012; 105.
- Lauraence DR, Bennett PN, Brown MJ. Unwanted effects and adverse drug reactions, Clinical Pharmacology, 8th edition; Churchill Livingstone. 1997; 121-137.
- Brown SD, Landry FJ. Recognizing Reporting and Reducing Adverse Drug Reactions, Sou Med Journal. 2001; 94: 370-372.
- Imbs JL. Latrogenic medication: Estimation of its prevalence in French public hospital-Review. 2015; 54: 21-27.
- Sudershan V, Siddiqua S, Aruna D, Manmohan, Ramesh S, Yasmeen N. Cutaneous adverse drug reactions in a tertiary care hospital. Der Pharmacia Lett. 201; 3(6): 210–217.
- Chatterjee S, Ghosh AP, Barbuiya J, Der SK. Adverse cutaneous drug reaction: a one year survey of a dermatology outpatient clinic of a tertiary care hospital, Indian J Pharmacol. 2006; 36(6): 429–431.
- Suthar J, Desai S. A study of Adverse Cutaneous Drug Reactions in Outdoor Patients attending to Skin and V.D, Department of Shree Krishna Hospital, Karamsad, Int J Res Pharm Biomed Sci. 2011; 2(1): 274–279.
- Nandha R, Gupta A, Hashmi A. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective. Int J of Appl and Bas Med Res. 2011; 1(1): 50–53.
- Mbuagbaw J, Egbembah L, Chiabi A, Bisseck C, Nkam M. Mucocutaneous Adverse Drug Reactions In A Hospital Setting In Cameroon. The Int J Derma. 2007; 6(2): 1-6.
- Shah SP, Desai MK, Dikshit RK. Analysis of Cutaneous Adverse Drug Reactions at a Tertiary Care Hospital – a Prospective Study. Trop J Pharm Res. 2011; 10(4): 517–522.
- Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents-A six-year series from Chandigarh. India. J Postgrad Med. 2001; 47: 95–99.
- Sushma M, Noel MV, Ritika MC, James J, Guido S. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf. 2005; 14(8): 567–570.
- Pudukadan D, Thappa DV. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereol Leprol. 2004; 70(1): 20–24.
- Dimple G, Bhatt SK, Malhotra S. Evaluation of Dermatological Adverse Drug Reaction in the Outpatient Department of Dermatology at a Tertiary Care Hospital, Ind Jour of Pharm Prac. 2014; 7(3): 42-49.
- Ghosh S, Acharya L, Rao P. Study and evaluation of various cutaneous adverse drug reactions in Kasturba Hospital, Manipal. Indian J Pharm Sci. 2006; 68(2): 212–15.
- Dubey AK, Prabhu S, Shankar PR, Subish P, Prabhu MM, Mishra. Dermatological adverse drug reactions due to systemic medications - A review of literature. J Pak Asso Dermat. 2006; 16: 28–38.
- Monalisa J, Mishra S, Panda M, Mishra SS. Cutaneous adverse drug reaction monitoring of different drugs in dermatology OPD of a tertiary care teaching hospital. Int J Cur Res Rev. 2013; 05: (07), 78.
- Chawla S. Adverse drug reaction monitoring in a tertiary care teaching hospital, India. Res letter. 2011; 2(3): 196-198.
- Lihite RJ, Lahkar M, Das S, Hazarika D, Kotni M, Maqbool M, Phukan S. A study on adverse drug reactions in a tertiary care hospital of Northeast India. Alexa Jour of Med. 2017; 53: 151–156.
Abstract Views: 275
PDF Views: 0